Related Experiment Video

Updated: Jun 1, 2026

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV
03:53

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV

Published on: November 10, 2023

The sponsored pandemic of the Mexican flu?

D Bijl1, H Schellekens

  • 1Domus Medica, Utrecht, The Netherlands. dick.bijl@hetnet.nl

The International Journal of Risk & Safety in Medicine
|June 16, 2011
PubMed

Insights

The 2009 H1N1 influenza pandemic was initially feared severe but proved mild. Concerns arose regarding the World Health Organization

Area of Science:

  • Public Health
  • Epidemiology
  • Medical Ethics

Background:

  • Initial reports of the 2009 Influenza A (H1N1) suggested high morbidity and mortality.
  • Subsequent observations indicated a milder clinical course than initially anticipated.
  • This discrepancy led to scrutiny of the World Health Organization's (WHO) pandemic declaration and expert advisory roles.

Purpose of the Study:

  • To examine the influence of potential conflicts of interest among experts advising the WHO.
  • To evaluate the decision-making processes regarding pandemic H1N1 vaccines and treatments.
  • To assess the impact of pharmaceutical industry ties on public health recommendations.

Main Methods:

  • Review of WHO pandemic declarations and expert panel compositions.
  • Analysis of scientific literature and public health guidelines concerning H1N1.
  • Investigation of financial disclosures and industry relationships of key advisors.

Main Results:

  • Evidence suggested a change in the definition of pandemic flu.
  • Conflicts of interest were identified among experts advising the WHO, particularly those with ties to vaccine and neuraminidase inhibitor manufacturers.
  • Doubts were raised about the efficacy and safety of oseltamivir, alongside evidence supporting single-dose vaccination.

Conclusions:

  • Political and economic factors, including pharmaceutical industry influence, may have impacted pandemic H1N1 response decisions.
  • The need for independent scientific advisory bodies free from conflicts of interest is highlighted.
  • Stricter measures are required to mitigate the influence of conflicted experts on public health guidelines and recommendations.

More Related Videos

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccinations01:51

Vaccinations

Overview
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Plague01:24

Plague

Plague is a highly virulent zoonotic disease caused by Yersinia pestis, a Gram-negative, facultatively anaerobic coccobacillus. This pathogen primarily circulates among rodent populations and is transmitted to humans through the bite of infected fleas. Additional transmission routes include direct contact with infected animal tissue or inhalation of respiratory droplets from individuals with pneumonic plague. These multiple transmission pathways highlight the bacterium’s potential for rapid...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.